Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alpha Teknova, Inc. - Common Stock (NQ:TKNO)

1.944 -0.146 (-6.99%)
Streaming Delayed Price Updated: 12:09 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpha Teknova, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova Announces New Board Member, Martha J. Demski
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Recap: Alpha Teknova Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For Alpha Teknova ↗
 
Via Benzinga
News headline image
Teknova Reports Second Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
State-of-the-art facility in Hollister, California is designed to help bioprocessing and gene therapy companies scale from research to clinical production 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For August 10, 2023 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
Results from the companies’ first collaboration show the successful achievement of more than 85% full AAV with 80-95% recoveries when pairing Sartorius BIA Separations’ monolithic purification platform... 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Alpha Teknova Set to Prosper from Expected Boom in Cell & Gene Therapies: KeyBanc Analyst ↗
KeyBanc Capital Markets has initiated coverage on Alpha Teknova Inc (NASDAQ: TKNO) with a  
Via Benzinga
News headline image
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process... 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023 ↗
 
Via Benzinga
News headline image
Teknova to Participate in Upcoming Investor Conference
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova Reports First Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Tuesday, 164 companies hit new 52-week lows. 
Via Benzinga
News headline image
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies
State-of-the-art screening kit – available for purchase today – could save months of process development time by helping gene therapy developers to identify the ideal buffer formulations for use during... 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 147 stocks made new 52-week lows. 
Via Benzinga
News headline image
Teknova Reports Fourth Quarter and Full Year 2022 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery 
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's session, 99 companies made new 52-week lows. 
Via Benzinga
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Teknova to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
News headline image
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. 
Via Benzinga
News headline image
Earnings Scheduled For March 15, 2023 ↗
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.